Gregory D Whitehill, Jaimy Joy, Francesco E Marino, Ryan J Krause, Suvadip Mallick, Hunter M Courtney, Kyewon Park, John W Carey, Rebecca Hoh, Heather Hartig, Vivian Pae, Sannidhi Sarvadhavabhatla, Maria Sophia B Donaire, Steven G Deeks, Rebecca M Lynch, Sulggi A Lee, Katharine J Bar
BACKGROUND: Early antiretroviral therapy initiation (ARTi) in HIV-1 restricts reservoir size and diversity while preserving immune function, potentially improving opportunities for immunotherapeutic cure strategies. For antibody-based cure approaches, the development of autologous neutralizing antibodies (anAb) after acute/early ARTi is relevant, but poorly understood. METHODS: We characterize antibody responses in a cohort of 23 participants following ARTi in acute HIV (<60 days after infection) and early HIV (60-128 days after infection)...
April 23, 2024: Journal of Clinical Investigation